AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32185595 — intervention group
Group type: COMPARATOR
Intervention: CFα standard start: CFα on day 2 + GnRH antagonist from day 6 + recFSH from day 9 (when needed)
Number of subjects: 113
Study 32185595 — intervention group
Group type: EXPERIMENTAL
Intervention: CFα late‐start
Number of subjects: 113
Study 32185595 — intervention group
Group type: COMPARATOR
Intervention: CFα standard regimen
Number of subjects: 113
Study 34725792 — intervention group
Group type: EXPERIMENTAL
Intervention: PIEB delivered at 125 mL·hr-1 (G125)
Number of subjects: 90
Study 34725792 — intervention group
Group type: COMPARATOR
Intervention: PIEB delivered at 250 mL·hr-1 (G250)
Number of subjects: 90
Study 34414606 — intervention group
Group type: EXPERIMENTAL
Intervention: RenalGuard® system (RG)
Number of subjects: 0
Study 34414606 — intervention group
Group type: COMPARATOR
Intervention: Current practice (control group)
Number of subjects: 0
Study 32232743 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-TLRC
Number of subjects: 106
Study 32232743 — intervention group
Group type: COMPARATOR
Intervention: 2D-TLRC
Number of subjects: 106
Study 34471952 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic pancreaticoduodenectomy (RPD)
Number of subjects: 92
Study 34471952 — intervention group
Group type: COMPARATOR
Intervention: Open pancreaticoduodenectomy (OPD)
Number of subjects: 92
Study 33525526 — intervention group
Group type: COMPARATOR
Intervention: DHA supplementation
Number of subjects: 10320
Study 36296919 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized Red Orange Extract
Number of subjects: 60
Study 34147125 — intervention group
Group type: EXPERIMENTAL
Intervention: ACD, BBC, and ABR grafting
Number of subjects: 40
Study 34147125 — intervention group
Group type: COMPARATOR
Intervention: ACD with β‐tricalcium phosphate (β‐TCP) granules and ABR grafting
Number of subjects: 40
Study 32865096 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranial electrotherapy stimulation (CES) pretreatment
Number of subjects: 80
Study 32865096 — intervention group
Group type: COMPARATOR
Intervention: No pretreatment (control group)
Number of subjects: 80
Study 35279929 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM)
Number of subjects: 760
Study 35279929 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 760
Study 34461224 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 0
Study 32601120 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral STN deep brain stimulation (DBS) plus optimal drug therapy (ODT)
Number of subjects: 28
Study 32601120 — intervention group
Group type: COMPARATOR
Intervention: Optimal drug therapy (ODT) alone
Number of subjects: 28
Study 35569129 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab (600 mg induction dose, followed by 300 mg every 2 weeks for patients ≥60 kg; 400 mg loading dose followed by 200 mg every 2 weeks for patients <60 kg)
Number of subjects: 27
Study 35569129 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 27
Study 33549820 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive elastic band resistance exercise training (peRET) for 12 weeks
Number of subjects: 27
Study 33549820 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 27
Study 34709130 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIT)
Number of subjects: 16
Study 34709130 — intervention group
Group type: COMPARATOR
Intervention: Control (sitting position, no exercise)
Number of subjects: 16
Study 33175585 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg daily)
Number of subjects: 3730
Study 33175585 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3730
Study 35325767 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS
Number of subjects: 40
Study 35325767 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 40
Study 35372879 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxalate decarboxylase (OxDC)
Number of subjects: 33
Study 33273258 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (28 sessions over 8 weeks)
Number of subjects: 560
Study 33273258 — intervention group
Group type: COMPARATOR
Intervention: Prucalopride (2 mg/d before breakfast over 32 weeks)
Number of subjects: 560
Study 33273258 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 560
Study 33273258 — intervention group
Group type: COMPARATOR
Intervention: Prucalopride
Number of subjects: 560
Study 34876848 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at Sanyinjiao (SP6) and Yinlingquan (SP9)
Number of subjects: 84
Study 34876848 — intervention group
Group type: COMPARATOR
Intervention: Lornoxicam
Number of subjects: 84
Study 33716173 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise (EX) plus 1% testosterone topical gel
Number of subjects: 0
Study 33716173 — intervention group
Group type: COMPARATOR
Intervention: Supervised exercise (EX) plus placebo gel
Number of subjects: 0
Study 33716173 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (EUC)
Number of subjects: 0
Study 32063519 — intervention group
Group type: EXPERIMENTAL
Intervention: Work-related rhinitis (WRR)
Number of subjects: 161
Study 32063519 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-work-related rhinitis (non-WRR)
Number of subjects: 161
Study 32063519 — intervention group
Group type: COMPARATOR
Intervention: Control group (no nasal symptoms)
Number of subjects: 161
Study 35761271 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly exenatide (EQW)
Number of subjects: 14665
Study 34085495 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized homeopathic medicines (IH)
Number of subjects: 128
Study 34085495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 36366201 — intervention group
Group type: EXPERIMENTAL
Intervention: VR‐3D stimulation
Number of subjects: 16
Study 36366201 — intervention group
Group type: COMPARATOR
Intervention: 2D stimulation
Number of subjects: 16
Study 35285115 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based pain and stress self-management intervention (PASS)
Number of subjects: 156
Study 35285115 — intervention group
Group type: COMPARATOR
Intervention: Individual physiotherapy (IPT)
Number of subjects: 156
Study 33530845 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic 3D HD system (system B)
Number of subjects: 62
Study 33530845 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic 4K UHD 2D system (system A)
Number of subjects: 62
Study 35857769 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive parenting programme (two 2‐hour interactive talks, total 4 hours)
Number of subjects: 144
Study 35857769 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive parenting programme
Number of subjects: 144
Study 35857769 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 69)
Number of subjects: 144
Study 36196685 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm-based difficult airway trolley (DAT)
Number of subjects: 16
Study 36196685 — intervention group
Group type: COMPARATOR
Intervention: Standard difficult airway trolley (DAT)
Number of subjects: 16
Study 36196685 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm-based DAT
Number of subjects: 16
Study 36196685 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher percentage of female team members
Number of subjects: 16
Study 34432394 — intervention group
Group type: COMPARATOR
Intervention: Manual method (n = 52)
Number of subjects: 157
Study 34432394 — intervention group
Group type: EXPERIMENTAL
Intervention: Reciprocating automated preparation system (WaveOne®) (n = 53)
Number of subjects: 157
Study 34432394 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotary preparation system (ProTaper Next®) (n = 52)
Number of subjects: 157
Study 34432394 — intervention group
Group type: EXPERIMENTAL
Intervention: All methods
Number of subjects: 157
Study 32605284 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot Juice (BJ)
Number of subjects: 12
Study 32605284 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12
Study 36197121 — intervention group
Group type: EXPERIMENTAL
Intervention: Intubation and sphincterotomy with wire-guided incision knife plus balloon dilatation (ISBD)
Number of subjects: 270
Study 36197121 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic sphincterotomy (EST)
Number of subjects: 270
Study 36197121 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic sphincterotomy plus balloon dilation
Number of subjects: 270
Study 34086880 — intervention group
Group type: EXPERIMENTAL
Intervention: AB023 (0.25 or 0.5 mg/kg)
Number of subjects: 24
Study 34086880 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 32594479 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized life skills training (2 sessions per week for 8 weeks, total 16 sessions)
Number of subjects: 32
Study 32594479 — intervention group
Group type: COMPARATOR
Intervention: Single-session awareness training (control group)
Number of subjects: 32
Study 32553558 — intervention group
Group type: EXPERIMENTAL
Intervention: alfapump® system implantation and concomitant hernia repair (CT group)
Number of subjects: 38
Study 32553558 — intervention group
Group type: COMPARATOR
Intervention: intermittent paracentesis hernia repair (ST group)
Number of subjects: 38
Study 32674231 — intervention group
Group type: EXPERIMENTAL
Intervention: B vitamins supplementation (folic acid and VB-6)
Number of subjects: 0
Study 32674231 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablet
Number of subjects: 0
Study 34667261 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD8529 (80 mg daily for 3 days)
Number of subjects: 26
Study 34667261 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 32819017 — intervention group
Group type: EXPERIMENTAL
Intervention: SBAR report to physician tool
Number of subjects: 165
Study 36174602 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH) doses adapted according to anti-Xa peak levels
Number of subjects: 91
Study 36174602 — intervention group
Group type: EXPERIMENTAL
Intervention: ClotPro analyses (viscoelastic hemostatic whole blood test)
Number of subjects: 91
Study 36174602 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher enoxaparin doses
Number of subjects: 91
Study 36174602 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring of anti-Xa levels
Number of subjects: 91
Study 36174602 — intervention group
Group type: EXPERIMENTAL
Intervention: ClotPro's RVV test
Number of subjects: 91
Study 33866248 — intervention group
Group type: EXPERIMENTAL
Intervention: CFI-400945 (PLK4 inhibitor) combined with radiation therapy
Number of subjects: 0
Study 33866248 — intervention group
Group type: COMPARATOR
Intervention: Control or single-agent treatment
Number of subjects: 0
Study 32700952 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological First Aid (PFA)
Number of subjects: 172
Study 32700952 — intervention group
Group type: COMPARATOR
Intervention: Usual Services (US)
Number of subjects: 172
Study 34937590 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline (200 mg/day)
Number of subjects: 71
Study 34937590 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 34937590 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 71
Study 33242870 — intervention group
Group type: EXPERIMENTAL
Intervention: Guggulu and Triphala
Number of subjects: 90
Study 33242870 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 36444987 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy (AT)
Number of subjects: 464
Study 36444987 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting with supportive care (WWSC)
Number of subjects: 464
Study 34992511 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-Body Vibration (WBV)
Number of subjects: 32
Study 34992511 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 32
Study 32739460 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic training (50-60 min/day, 3 days/week at 65-70% of maximal heart rate reserve) for 12 weeks
Number of subjects: 29
Study 32739460 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention, maintained normal lifestyle)
Number of subjects: 29
Study 32542627 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol supplementation
Number of subjects: 553
Study 32542627 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 553
Study 34582258 — intervention group
Group type: EXPERIMENTAL
Intervention: Keenoa™ diet tracking application
Number of subjects: 102
Study 34582258 — intervention group
Group type: COMPARATOR
Intervention: Conventional pen and paper method
Number of subjects: 102
Study 33256546 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual modality
Number of subjects: 262
Study 33256546 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative style
Number of subjects: 262
Study 34396709 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored website intervention
Number of subjects: 0
Study 34396709 — intervention group
Group type: EXPERIMENTAL
Intervention: Untailored website intervention
Number of subjects: 0
Study 34396709 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 32701865 — intervention group
Group type: EXPERIMENTAL
Intervention: Test group with access to the knot-tying station plus the knot testing station
Number of subjects: 60
Study 32701865 — intervention group
Group type: COMPARATOR
Intervention: Control group with access to only the knot-tying station
Number of subjects: 60
Study 32055864 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 consecutive night shifts
Number of subjects: 73
Study 32055864 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 consecutive night shifts
Number of subjects: 73
Study 32055864 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 consecutive night shifts
Number of subjects: 73
Study 32055864 — intervention group
Group type: COMPARATOR
Intervention: Recovery days (2+2, 4+4, 7+7)
Number of subjects: 73
Study 32672635 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-Tenon injection of 0.1 ml of 0.01% MMC (TI group)
Number of subjects: 82
Study 32672635 — intervention group
Group type: COMPARATOR
Intervention: Subconjunctival application of MMC-soaked sponges (TS group)
Number of subjects: 82
Study 35451013 — intervention group
Group type: EXPERIMENTAL
Intervention: 1, 2, 4, 8 or 12 µg CG beta added to follitropin delta
Number of subjects: 620
Study 35451013 — intervention group
Group type: COMPARATOR
Intervention: Follitropin delta only
Number of subjects: 620
Study 35451013 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 620
Study 33106225 — intervention group
Group type: EXPERIMENTAL
Intervention: Very early ECMO plus standard pharmacotherapy
Number of subjects: 428
Study 33106225 — intervention group
Group type: COMPARATOR
Intervention: Standard pharmacotherapy alone
Number of subjects: 428
Study 35589611 — intervention group
Group type: EXPERIMENTAL
Intervention: Biocon's Insulin‐70/30
Number of subjects: 78
Study 35589611 — intervention group
Group type: COMPARATOR
Intervention: HUMULIN‐70/30
Number of subjects: 78
Study 34628377 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamellar immediate-prostheses under the control of diagnostic staining of the mucous membrane
Number of subjects: 2
Study 34628377 — intervention group
Group type: COMPARATOR
Intervention: Traditional method of prosthesis manufacture
Number of subjects: 2
Study 36000541 — intervention group
Group type: EXPERIMENTAL
Intervention: Zanidatamab plus chemotherapy
Number of subjects: 0
Study 36000541 — intervention group
Group type: EXPERIMENTAL
Intervention: Zanidatamab plus chemotherapy + tislelizumab
Number of subjects: 0
Study 36000541 — intervention group
Group type: COMPARATOR
Intervention: Trastuzumab plus chemotherapy (standard of care)
Number of subjects: 0
Study 32536177 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg every 12 hours for 10 days
Number of subjects: 179
Study 32536177 — intervention group
Group type: COMPARATOR
Intervention: Control group (no NAC)
Number of subjects: 179
Study 35175092 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD Coach Online (culturally adapted web-based intervention)
Number of subjects: 87
Study 33863241 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity parent advocacy program (three sessions)
Number of subjects: 0
Study 33222860 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic therapy (tulathromycin, 2.5 mg/kg subcutaneous)
Number of subjects: 357
Study 33222860 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sterile saline, equal volume subcutaneous)
Number of subjects: 357
Study 35993223 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor canal block (ACB) with 15 mL mixture of ropivacaine 0.2% with isotonic saline and steroids on post-operative day 14 (POD-14)
Number of subjects: 70
Study 35993223 — intervention group
Group type: COMPARATOR
Intervention: Daily consumption of analgesic (control group)
Number of subjects: 70
Study 36250527 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted eating (TRE) group (n=11)
Number of subjects: 19
Study 36250527 — intervention group
Group type: COMPARATOR
Intervention: Control group (unrestricted feeding; n=8)
Number of subjects: 19
Study 35195052 — intervention group
Group type: EXPERIMENTAL
Intervention: B-vitamin supplementation
Number of subjects: 707
Study 35195052 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 707
Study 34260816 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 1155
Study 34260816 — intervention group
Group type: COMPARATOR
Intervention: Dalteparin
Number of subjects: 1155
Study 34810130 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemotherapy-immunotherapy with pembrolizumab and multisite radiotherapy
Number of subjects: 460
Study 34810130 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemotherapy-immunotherapy with pembrolizumab
Number of subjects: 460
Study 36208670 — intervention group
Group type: COMPARATOR
Intervention: Control (2% dimethyl sulfoxide, 2% Ringer, 96% propylene glycol)
Number of subjects: 32
Study 36208670 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mM Ascorbate (non-specific ROS inhibitor)
Number of subjects: 32
Study 36208670 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mM L-NAME (non-specific NOS inhibitor)
Number of subjects: 32
Study 36208670 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbate+L-NAME
Number of subjects: 32
Study 34186271 — intervention group
Group type: EXPERIMENTAL
Intervention: Metacognitive training (MCT)
Number of subjects: 122
Study 34186271 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation
Number of subjects: 122
Study 32460793 — intervention group
Group type: EXPERIMENTAL
Intervention: T-Beer group (alcohol beer, 5.4%; n=13)
Number of subjects: 73
Study 32460793 — intervention group
Group type: EXPERIMENTAL
Intervention: T-Ethanol group (sparkling water with vodka, 5.4%; n=14)
Number of subjects: 73
Study 32460793 — intervention group
Group type: EXPERIMENTAL
Intervention: T-Water group (sparkling water, 0.0%; n=16)
Number of subjects: 73
Study 32460793 — intervention group
Group type: EXPERIMENTAL
Intervention: T-0.0Beer group (alcohol-free beer, 0.0%; n=15)
Number of subjects: 73
Study 32460793 — intervention group
Group type: COMPARATOR
Intervention: Control Non-Training group (n=15)
Number of subjects: 73
Study 33279444 — intervention group
Group type: EXPERIMENTAL
Intervention: Bidirectional continuous barbed suture (Quill™)
Number of subjects: 82
Study 33279444 — intervention group
Group type: COMPARATOR
Intervention: Discontinuous polyglactin 910 suture (Vicryl™)
Number of subjects: 82
Study 32406783 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic Camera Steering Device (RCSD) controlled by head movements
Number of subjects: 45
Study 32406783 — intervention group
Group type: COMPARATOR
Intervention: Human camera assistant
Number of subjects: 45
Study 35224588 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice packs (0 °C)
Number of subjects: 90
Study 35224588 — intervention group
Group type: COMPARATOR
Intervention: Placebo cold packs (10 °C)
Number of subjects: 90
Study 33143009 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led physical activity intervention
Number of subjects: 0
Study 33143009 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer supporters
Number of subjects: 0
Study 33143009 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led interventions
Number of subjects: 0
Study 35318946 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical training program (2-month duration)
Number of subjects: 147
Study 36182207 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% sodium hypochlorite deproteinization
Number of subjects: 40
Study 36182207 — intervention group
Group type: EXPERIMENTAL
Intervention: Transbond XT adhesive
Number of subjects: 40
Study 36182207 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthocem adhesive
Number of subjects: 40
Study 36182207 — intervention group
Group type: COMPARATOR
Intervention: Control group (no deproteinization)
Number of subjects: 40
Study 34674645 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly multidisciplinary team‐led deprescribing rounds (using five steps of deprescribing)
Number of subjects: 260
Study 34674645 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 260
Study 32393353 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral Salter pelvic osteotomy
Number of subjects: 15
Study 32393353 — intervention group
Group type: COMPARATOR
Intervention: Bilateral Salter pelvic osteotomy
Number of subjects: 15
Study 35083495 — intervention group
Group type: EXPERIMENTAL
Intervention: Local hyperthermia
Number of subjects: 1027
Study 35083495 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 1027
Study 33907393 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized glycopyrrolate (GLY)
Number of subjects: 1293
Study 33907393 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1293
Study 33337492 — intervention group
Group type: EXPERIMENTAL
Intervention: Volar locking plate internal fixation
Number of subjects: 146
Study 33337492 — intervention group
Group type: COMPARATOR
Intervention: External fixation
Number of subjects: 146